Spotlight on ExPrimary: Improving Access to Bioanalytical Tools
Most people only see their doctor once a year, contributing to a lack of data points and ultimately a reactive approach to disease. ExPrimary, Inc., a Luminate cohort III startup, is miniaturizing bioanalytical tools to bring them closer to the individual. With more accessible tools and testing comes more data points, which increases the ability to identify trends and catch diseases at an earlier, more treatable stage.
Luminate Technology Program Manager, Damon Diehl, PhD, spoke with ExPrimary President and CEO, Sean Higgins, PhD, about how his startup’s work will help usher in more preventative healthcare.
Learn more about ExPrimary at exprimary.com.
Subscribe to Forward Faster
